- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 327
LightCyber detects Access for $20m round
Access Industries' Israel-based subsidiary co-led cyberthreat detection software provider LightCyber's latest round, taking its overall funding to more than $31m.
Jun 23, 2016Novartis spells out series A support for IFM
Novartis has supplied cash to IFM Therapeutics' $27m series A round to help the biopharmaceutical company's efforts to develop a cancer treatment.
Jun 23, 2016Legend Holdings tunes into Kaola FM
Kaolo FM, a network operated by AutoRadio Group, has raised $26m in a round featuring Legend's corporate venturing unit.
Jun 22, 2016Ant Financial looks to Ascend
Alibaba's financial services affiliate is set to take a 20% stake in Thailand-based Ascend Money, shortly after investing $35m in Shanghai Suntime Information Technology.
Jun 21, 2016Andela recruits GV for $24m series B
The Alphabet subsidiary has taken part in a round for Andela, which recruits Africa-based programmers on behalf of US tech companies.
Jun 20, 2016SI-Bone connects to $20m
Novo-backed SI-Bone has added $20m to its coffers in a funding round led by Arboretum Ventures that featured all its major existing shareholders.
Jun 20, 2016Mersana flexes for $33m
Takeda, which formed a strategic partnership agreement with Mersana in February, has taken part in a series C round to help the company expand its Fleximer platform.
Jun 20, 2016Collective Media assembles $34m in investment
The adtech company, backed by Cox Media and Samsung, has increased its total funding by $34m to support further development of its enterprise advertising hub.
Jun 17, 2016Rgenix generates $33m in series B round
Novo and Sofinnova Partners have co-led a series B round for Rgenix, a spinout of Rockefeller University that hopes to enter two immunotherapies into clinical trials this autumn.
Jun 16, 2016Rgenix generates $33m in series B round
Novo and Sofinnova Partners have co-led a series B round for Rgenix, which is preparing to enter two immunotherapies into clinical trials this autumn.
Jun 16, 2016About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


